Most Read News

Earlier this week, Bahadur Dastoor resigned as the company's Chief Financial Officer (CFO), effective September 21.

Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.

Recently, RITES announced a bonus share allotment of 1:1 and a final dividend of ₹5 per share for eligible shareholders.

However, it is unclear whether the Hyderabad-based company will be Cobenfy's exclusive supplier.

The order is for the procurement of materials and installation of a solar power producing plant of 130 MWp/100 MWac.

The company's claimed reasons for the split include increased share liquidity, affordability, and a broader investor base.

On the NSE, market breadth shows 1,322 stocks advancing while 1,146 stocks are declining.

The sale was formalized through a deed of conveyance on September 26, 2024, encompassing both the land and building associated with the property.

The company said that ₹592.26 Crore will be paid in cash, while ₹239.25 Crore will be paid through a share transfer, resulting in a 3.17% holding in Nazara.

In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.